CDK1 and renal carcinoma: Western blotting analysis also indicated that pretreatment with NAC notably prevented the down‐regulation of cell cycle‐related proteins, such as CDC2, MDM‐2 and Cyclin B1 in human renal cancer cells (Figure S5E‐H).